Time to Drop This Drug Stock

Existing home sales fell by 1.7% in June

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     7/23/2019
A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Coca-Cola Earnings Power Dow Surge By Patrick Martin Share On The Dow Jones Industrial Average (DJI) is enjoying solid gains today, thanks to a strong earnings reaction for blue chip Coca-Cola (KO). News that Apple (AAPL) is buying Intel's (INTC) modem business is also creating tailwinds for the Dow. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are higher, too, on a post-earnings pop for toy stock Hasbro (HAS). Today's positive price action comes despite a drop in existing home sales, which fell by 1.7% in June, greater than the anticipated 0.2% dip.  Continue reading for more on today's market, including:  Analyst makes big call on Spotify stock. History says it's time to drop this drug stock. Plus, options bears eye L Brands; Biogen breaks out after earnings; and PulteGroup sinks on a dismal home sales forecast. >> Continue reading...
LATEST HEADLINES
>> Drug Stock With Cheap Options Sounds Bear Signal Short-term options are pricing in low volatility expectations right now >> Target Stock Could See a Bounce Before Earnings The retailer just pulled back to a historically bullish signal on the charts >> Hasbro Thanks "Avengers" Toys for Earnings Beat Hasbro reported second-quarter earnings and revenue that exceeded expectations >> Coca-Cola Earnings Reaction Sparks Heavy Call Volume Analysts remain skeptical of the beverage giant, though >> Macquarie Makes Big Call on Spotify Stock SPOT options traders are heavily call-skewed ADVERTISEMENT Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com